NATHAN WESTERCAMP: Open Payments
NPI 1639441405 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 16 payments from 12 companies in 2025. Trend: 2023 $13 · 2024 $182 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 2 | $160 |
| AstraZeneca Pharmaceuticals LP | 2 | $65 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Davol Inc. | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $27 |
| Genentech USA, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| On Target Laboratories, Inc | 1 | $21 |
Products named: ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, KEYTRUDA, LIBTAYO, ARISTA, TAGRISSO, ALUNBRIG, Zoladex, Tecentriq.
Industry payments across GA — which companies pay providers there.
